We hypothesize that administration of intranasal insulin: 1. Inhibits endogenous glucose production, indepently of systemic insulin; 2. Increases the insulin concentration in the cerebrospinal fluid (CSF).
ID
Bron
Verkorte titel
Aandoening
Diabetes Mellitus type II (DM II)
glucose metabolism/glucose metabolisme
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Endogenous glocose production.
Achtergrond van het onderzoek
Insulin is mainly known for its peripheral effects on the metabolism of glucose, fat and protein. The role of insulin signaling in the brain is only incompletely understood. To best way to study the effects of insulin in the brain, with low levels of insulin in the systemic circulations, is by administering it intranasally.
10 healthy male subjects will be studied twice, after administration of intranasal insulin and placebo. Glucose metabolism will be measured in the basal state and after administration of insulin/placebo, using stable isotopes. An intraspinal catheter will be inserted during the insulin study-day to measure the concentration of insulin in the CSF.
Doel van het onderzoek
We hypothesize that administration of intranasal insulin:
1. Inhibits endogenous glucose production, indepently of systemic insulin;
2. Increases the insulin concentration in the cerebrospinal fluid (CSF).
Onderzoeksopzet
Every 10 - 30 minutes after intranasal insulin/placebo.
Onderzoeksproduct en/of interventie
Each subject will be studied twice. Intranasal insulin and placebo will be administered. Glucose metabolism will be measured using stable isotopes. An intraspinal catheter will be inserted during the insulin-study day to measure the concentration of insulin in the CSF.
Publiek
Department of Endocrinology & Metabolism<br>
F5-162
N.M. Lammers
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
+31 (0)20 5662663
N.M.Lammers@amc.uva.nl
Wetenschappelijk
Department of Endocrinology & Metabolism<br>
F5-162
N.M. Lammers
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
+31 (0)20 5662663
N.M.Lammers@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Lean healthy male volunteers;
2. Age 18-35 years;
3. BMI 20-25 kg/m2;
4. Normal oral glucose intolerance test according to the ADA-criteria.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Any medication or substance use;
2. DM II;
3. Smoking;
4. Alcohol abuse (>3/day);
5. Lipid disorders, renal insufficiency, elevated liver enzymes or TSH;
6. Bleeding disorders;
7. Prior surgery of the nose and/or septum;
8. Allergic rhinitis;
9. Known allergies to antibiotics, used as prophylaxis in this study.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL1884 |
| NTR-old | NTR1998 |
| Ander register | METC Academic medical center : MEC 09/121 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |